Top

BMC Cancer

Published in:

Open Access 01-12-2024 | Piperacillin | Research

Antibiotic prophylaxis with piperacillin–tazobactam reduces organ/space surgical site infection after pancreaticoduodenectomy: a retrospective and propensity score-matched analysis

Authors: Yifei Yang, Jianjie Sheng, Zhenghua Cai, Linxi Zhu, Chenglin Lu, Liang Mao, Yudong Qiu, Xu Fu

Published in: BMC Cancer | Issue 1/2024

Abstract

Background

The occurrence of surgical site infection (SSI) after pancreaticoduodenectomy (PD) is still relatively high. The aim of this retrospective study is to evaluate the efficacy of piperacillin-tazobactam as perioperative prophylactic antibiotic on organ/space SSI for patients underwent PD.

Methods

Four hundred seven consecutive patients who underwent PD between January 2018 and December 2022 were enrolled and analyzed retrospectively. The univariate and multivariate analysis were used to identify independent risk factors of organ/space SSI. Postoperative complications were compared between the two groups according to the use of prophylactic antibiotics by a ratio of 1:1 propensity score-matched (PSM) analysis.

Results

Based on perioperative prophylactic antibiotic use, all 407 patients were divided into the ceftriaxone group (n = 192, 47.2%) and piperacillin–tazobactam group (n = 215, 52.8%). The rate of organ/space SSI was 31.2% with the choice of perioperative antibiotics (OR = 2.837, 95%CI = 1.802–4.465, P < 0.01) as one of independent risk factors. After PSM, there were similar baseline characteristics among the groups. Meanwhile, the piperacillin–tazobactam group had a significant lower rate of organ/space SSI compared to the ceftriaxone group both before and after PSM(P < 0.05).

Conclusions

The adoption of piperacillin–tazobactam as perioperative prophylaxis for patients underwent PD reduced organ/space SSI significantly.

Available only for authorised users

D’Angelica MI, Ellis RJ, Liu JB, Brajcich BC, Gönen M, et al. Piperacillin-tazobactam compared with cefoxitin as antimicrobial prophylaxis for pancreatoduodenectomy: a randomized clinical trial. JAMA. 2023;329(18):1579–88. https://doi.org/10.1001/jama.2023.5728.CrossRefPubMedPubMedCentral

Fu X, Yang Y, Mao L, Qiu Y. Risk factors and microbial spectrum for infectious complications after pancreaticoduodenectomy. Gland Surg. 2021;10(12):3222–32. https://doi.org/10.21037/gs-21-590.CrossRefPubMedPubMedCentral

Kone LB, Torres C, Banulescu M, Maker VK, Maker AV. Perioperative broad-spectrum antibiotics are associated with decreased surgical site infections compared to 1st-3rd generation Cephalosporins after Open Pancreaticoduodenectomy in patients with jaundice or a biliary stent. Ann Surg. 2022;275(6):1175–83. https://doi.org/10.1097/SLA.0000000000004216.CrossRefPubMed

Beane JD, Borrebach JD, Zureikat AH, Kilbane EM, Thompson VM, Pitt HA. Optimal pancreatic surgery: are we making progress in North America. Ann Surg. 2021;274(4):e355-5363. https://doi.org/10.1097/SLA.0000000000003628.CrossRefPubMed

Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt). 2013;14(1):73–156. https://doi.org/10.1089/sur.2013.9999.CrossRefPubMed

Lübbert C, Wendt K, Feisthammel J, Moter A, Lippmann N, Busch T, et al. Epidemiology and resistance patterns of bacterial and fungal colonization of biliary plastic stents: a prospective cohort study. PLoS ONE. 2016;11(5): e0155479. https://doi.org/10.1371/journal.pone.0155479.CrossRefPubMedPubMedCentral

Macedo F, Mowzoon M, Parikh J, Sathyanarayana SA, Jacobs MJ. Disparities in the management and prophylaxis of surgical site infection and pancreatic fistula after pancreatoduodenectomy. J Hepatobiliary Pancreat Sci. 2017;24(5):268–80. https://doi.org/10.1002/jhbp.443.CrossRefPubMed

Gavazzi F, Ridolfi C, Capretti G, Angiolini MR, Morelli P, Casari E, et al. Role of preoperative biliary stents, bile contamination and antibiotic prophylaxis in surgical site infections after pancreaticoduodenectomy. BMC Gastroenterol. 2016;16:43. https://doi.org/10.1186/s12876-016-0460-1.CrossRefPubMedPubMedCentral

Donald GW, Sunjaya D, Lu X, Chen F, Clerkin B, Eibl G, et al. Perioperative antibiotics for surgical site infection in pancreaticoduodenectomy: does the SCIP-approved regimen provide adequate coverage. Surgery. 2013;154(2):190–6. https://doi.org/10.1016/j.surg.2013.04.001.CrossRefPubMed

10.

De Pastena M, Paiella S, Azzini AM, Zaffagnini A, Scarlini L, Montagnini G, et al. Antibiotic prophylaxis with piperacillin-tazobactam reduces post-operative infectious complication after pancreatic surgery: an Interventional, non-randomized study. Surg Infect (Larchmt). 2021;22(5):536–42. https://doi.org/10.1089/sur.2020.260.CrossRefPubMed

11.

Yang Y, Fu X, Cai Z, Qiu Y, Mao L. The occurrence of Klebsiella pneumoniae in drainage fluid after pancreaticoduodenectomy: risk factors and clinical impacts. Front Microbiol. 2021;12: 763296. https://doi.org/10.3389/fmicb.2021.763296.CrossRefPubMedPubMedCentral

12.

Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36(5):309–32. https://doi.org/10.1016/j.ajic.2008.03.002.CrossRefPubMed

13.

Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13. https://doi.org/10.1097/01.sla.0000133083.54934.ae.CrossRefPubMedPubMedCentral

14.

Besselink MG, van Rijssen LB, Bassi C, Dervenis C, Montorsi M, Adham M, et al. Definition and classification of chyle leak after pancreatic operation: a consensus statement by the International Study Group on pancreatic surgery. Surgery. 2017;161(2):365–72. https://doi.org/10.1016/j.surg.2016.06.058.CrossRefPubMed

15.

Wente MN, Veit JA, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of pancreatic surgery (ISGPS) definition. Surgery. 2007;142(1):20–5. https://doi.org/10.1016/j.surg.2007.02.001.CrossRefPubMed

16.

Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388–416. https://doi.org/10.1164/rccm.200405-644ST.

17.

Degrandi O, Buscail E, Martellotto S, Gronnier C, Collet D, Adam JP, et al. Perioperative antibiotherapy should replace prophylactic antibiotics in patients undergoing pancreaticoduodenectomy preceded by preoperative biliary drainage. J Surg Oncol. 2019;120(4):639–45. https://doi.org/10.1002/jso.25622.CrossRefPubMed

18.

Tanaka K, Nakamura T, Imai S, Kushiya H, Miyasaka D, Nakanishi Y, et al. The use of broad-spectrum antibiotics reduces the incidence of surgical site infection after pancreatoduodenectomy. Surg Today. 2018;48(9):825–34. https://doi.org/10.1007/s00595-018-1658-3.CrossRefPubMed

19.

Zhu L, Li T, Yang Y, Tang N, Fu X, Qiu Y. Development and validation of a nomogram for predicting post-operative abdominal infection in patients undergoing pancreaticoduodenectomy. Clin Chim Acta. 2022;534:57–64. https://doi.org/10.1016/j.cca.2022.07.003.CrossRefPubMed

20.

Limongelli P, Pai M, Bansi D, Thiallinagram A, Tait P, Jackson J, et al. Correlation between preoperative biliary drainage, bile duct contamination, and postoperative outcomes for pancreatic surgery. Surgery. 2007;142(3):313–8. https://doi.org/10.1016/j.surg.2007.04.022.CrossRefPubMed

21.

Fong ZV, McMillan MT, Marchegiani G, Sahora K, Malleo G, De Pastena M, et al. Discordance between perioperative antibiotic prophylaxis and wound infection cultures in patients undergoing pancreaticoduodenectomy. JAMA Surg. 2016;151(5):432–9. https://doi.org/10.1001/jamasurg.2015.4510.CrossRefPubMed

22.

Mohammed S, Evans C, VanBuren G, Hodges SE, Silberfein E, Artinyan A, et al. Treatment of bacteriobilia decreases wound infection rates after pancreaticoduodenectomy. HPB (Oxford). 2014;16(6):592–8. https://doi.org/10.1111/hpb.12170.CrossRefPubMed

23.

Sugiura T, Mizuno T, Okamura Y, Ito T, Yamamoto Y, Kawamura I, et al. Impact of bacterial contamination of the abdominal cavity during pancreaticoduodenectomy on surgical-site infection. Br J Surg. 2015;102(12):1561–6. https://doi.org/10.1002/bjs.9899.CrossRefPubMed

24.

Zhu L, Yang Y, Cheng H, Cai Z, Tang N, Mao L, et al. The role of preoperative biliary drainage on postoperative outcome after pancreaticoduodenectomy in patients with obstructive jaundice. Gland Surg. 2023;12(5):593–608. https://doi.org/10.21037/gs-22-648.CrossRefPubMedPubMedCentral

25.

Chinikar R, Patricio D, Gosse J, Ickx B, Delhaye M, Closset J, et al. Perioperative antimicrobial prophylaxis in patients undergoing pancreatoduodenectomy: retrospective analysis of bacteriological profile and susceptibility. Acta Chir Belg. 2023;123(4):337–44. https://doi.org/10.1080/00015458.2021.2006887.CrossRefPubMed

26.

Sudo T, Murakami Y, Uemura K, Hayashidani Y, Hashimoto Y, Ohge H, et al. Specific antibiotic prophylaxis based on bile cultures is required to prevent postoperative infectious complications in pancreatoduodenectomy patients who have undergone preoperative biliary drainage. World J Surg. 2007;31(11):2230–5. https://doi.org/10.1007/s00268-007-9210-4.CrossRefPubMed

27.

Augenstein VA, Reuter NP, Bower MR, McMasters KM, Scoggins CR, Martin RC. Bile cultures: a guide to infectious complications after pancreaticoduodenectomy. J Surg Oncol. 2010;102(5):478–81. https://doi.org/10.1002/jso.21612.CrossRefPubMed

28.

Sudo T, Murakami Y, Uemura K, Hashimoto Y, Kondo N, Nakagawa N, et al. Perioperative antibiotics covering bile contamination prevent abdominal infectious complications after pancreatoduodenectomy in patients with preoperative biliary drainage. World J Surg. 2014;38(11):2952–9. https://doi.org/10.1007/s00268-014-2688-7.CrossRefPubMed

29.

Belmouhand M, Krohn PS, Svendsen LB, Henriksen A, Hansen CP, Achiam MP. The occurrence of Enterococcus faecium and faecalis is significantly associated with anastomotic leakage after pancreaticoduodenectomy. Scand J Surg. 2018;107(2):107–13. https://doi.org/10.1177/1457496917731188.CrossRefPubMed

30.

Shogan BD, Belogortseva N, Luong PM, Zaborin A, Lax S, Bethel C, et al. Collagen degradation and MMP9 activation by enterococcus faecalis contribute to intestinal anastomotic leak. Sci Transl Med. 2015;7(286):286ra68. https://doi.org/10.1126/scitranslmed.3010658.CrossRefPubMedPubMedCentral

31.

Wiegerinck M, Hyoju SK, Mao J, Zaborin A, Adriaansens C, Salzman E, et al. Novel de novo synthesized phosphate carrier compound ABA-PEG20k-Pi20 suppresses collagenase production in Enterococcus faecalis and prevents colonic anastomotic leak in an experimental model. Br J Surg. 2018;105(10):1368–76. https://doi.org/10.1002/bjs.10859.CrossRefPubMed

32.

Takahashi Y, Takesue Y, Fujiwara M, Tatsumi S, Ichiki K, Fujimoto J, et al. Risk factors for surgical site infection after major hepatobiliary and pancreatic surgery. J Infect Chemother. 2018;24(9):739–43. https://doi.org/10.1016/j.jiac.2018.05.007.CrossRefPubMed

33.

Droogh D, Groen JV, de Boer M, van Prehn J, Putter H, Bonsing BA, et al. Prolonged antibiotic prophylaxis after pancreatoduodenectomy: systematic review and meta-analysis. Br J Surg. 2023;110(11):1458–66. https://doi.org/10.1093/bjs/znad213.CrossRefPubMedPubMedCentral

34.

Tarvainen T, Bonsdorff A, Kolho E, Sirén J, Kokkola A, Sallinen V. Association of cephalosporin resistance in intraoperative biliary cultures with surgical site infections in patients undergoing pancreaticoduodenectomy. A retrospective cohort study. HPB (Oxford). 2023. https://doi.org/10.1016/j.hpb.2023.10.011.

Title: Antibiotic prophylaxis with piperacillin–tazobactam reduces organ/space surgical site infection after pancreaticoduodenectomy: a retrospective and propensity score-matched analysis
Authors: Yifei Yang
Jianjie Sheng
Zhenghua Cai
Linxi Zhu
Chenglin Lu
Liang Mao
Yudong Qiu
Xu Fu
Publication date: 01-12-2024
Publisher: BioMed Central
Keywords: Piperacillin
Antibiotic
Ceftriaxone
Published in: BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-024-11955-x

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2024

Pre-operative vs. post-operative stereotactic radiosurgery for operative metastatic brain tumors: study protocol for a phase III clinical trial

Expression and prognostic value of APOBEC2 in gastric adenocarcinoma and its association with tumor-infiltrating immune cells

Clinical study of thoracoscopic assisted different surgical approaches for early thymoma: a meta-analysis

25-hydroxycholesterol promotes proliferation and metastasis of lung adenocarcinoma cells by regulating ERβ/TNFRSF17 axis

A multicentric, single arm, open-label, phase I/II study evaluating PSMA targeted radionuclide therapy in adult patients with metastatic clear cell renal cancer (PRadR)

Effect of exercise-based cancer rehabilitation via telehealth: a systematic review and meta-analysis

Keynote webinar | Spotlight on antibody–drug conjugates in cancer